Encore medical divests non-core US consumer line to Biomedical:
This article was originally published in Clinica
Executive Summary
Encore Medical is to sell its Slendertone US consumer business for approximately $6.8m in cash to Bio-Medical Research, the Irish company that developed, manufactures, distributes and owns all intellectual property rights to the Slendertone product line. The transaction, expected to close by the end of June, encompasses the Slendertone inventory and all of Encore's US distribution rights to the products. Proceeds from the sale will be invested into the Austin, Texas company's core surgical implant and orthopaedic rehabilitation businesses. Encore had acquired the US Slendertone unit as part of its acquisition of the electrotherapy company Compex Technologies, which was completed in February 2006 (see Clinica No 1196, p 14).